ARTICLE | Financial News
miRagen raises $20 million in series B
April 25, 2012 1:04 AM UTC
MicroRNA company miRagen Therapeutics Inc. (Boulder, Colo.) raised $20 million in a series B round led by new investor Remeditex Ventures. Existing investors Atlas Venture; Boulder Ventures; Amgen Ven...